Medical Care
Global mRNA Cancer Vaccines and Therapeutics Market Research Report 2024
- Jan 18, 24
- ID: 4331
- Pages: 84
- Figures: 165
- Views: 53
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global mRNA Cancer Vaccines and Therapeutics market was valued at US$ 140.4 million in 2023 and is anticipated to reach US$ 480.9 million by 2030, witnessing a CAGR of 19.0% during the forecast period 2024-2030.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
This report aims to provide a comprehensive presentation of the global market for mRNA Cancer Vaccines and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Cancer Vaccines and Therapeutics.
Report Scope
The mRNA Cancer Vaccines and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Cancer Vaccines and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Cancer Vaccines and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Segment by Application
Infectious Disease
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Cancer Vaccines and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global mRNA Cancer Vaccines and Therapeutics market was valued at US$ 140.4 million in 2023 and is anticipated to reach US$ 480.9 million by 2030, witnessing a CAGR of 19.0% during the forecast period 2024-2030.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
This report aims to provide a comprehensive presentation of the global market for mRNA Cancer Vaccines and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Cancer Vaccines and Therapeutics.
Report Scope
The mRNA Cancer Vaccines and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Cancer Vaccines and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Cancer Vaccines and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Segment by Application
Infectious Disease
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Cancer Vaccines and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2019-2030)
2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Region
2.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 mRNA Cancer Vaccines and Therapeutics Market Dynamics
2.3.1 mRNA Cancer Vaccines and Therapeutics Industry Trends
2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2019-2024)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2023
3.5 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
3.6 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2025-2030)
5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024)
9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Detail
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Detail
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
11.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Detail
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Detail
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Detail
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Detail
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Detail
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Detail
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Detail
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Detail
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.10.5 Tiba Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2019-2030)
2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Region
2.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 mRNA Cancer Vaccines and Therapeutics Market Dynamics
2.3.1 mRNA Cancer Vaccines and Therapeutics Industry Trends
2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2019-2024)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2023
3.5 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
3.6 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2025-2030)
5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024)
9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Detail
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Detail
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
11.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Detail
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Detail
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Detail
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Detail
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Detail
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Detail
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Detail
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Detail
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
11.10.5 Tiba Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Adeno Carcinomas
Table 3. Key Players of Mucinous Carcinomas
Table 4. Key Players of Adenosquamous Carcinomas
Table 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2019-2024)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2025-2030)
Table 11. mRNA Cancer Vaccines and Therapeutics Market Trends
Table 12. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 13. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 14. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 15. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2023)
Table 18. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
Table 22. Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Moderna Therapeutics Company Detail
Table 48. Moderna Therapeutics Business Overview
Table 49. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 50. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Moderna Therapeutics Recent Development
Table 52. CureVac Company Detail
Table 53. CureVac Business Overview
Table 54. CureVac mRNA Cancer Vaccines and Therapeutics Product
Table 55. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 56. CureVac Recent Development
Table 57. Translate Bio Company Detail
Table 58. Translate Bio Business Overview
Table 59. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
Table 60. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Translate Bio Recent Development
Table 62. BioNTech Company Detail
Table 63. BioNTech Business Overview
Table 64. BioNTech mRNA Cancer Vaccines and Therapeutics Product
Table 65. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 66. BioNTech Recent Development
Table 67. Sangamo Therapeutics Company Detail
Table 68. Sangamo Therapeutics Business Overview
Table 69. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 70. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Sangamo Therapeutics Recent Development
Table 72. Argos Therapeutics Company Detail
Table 73. Argos Therapeutics Business Overview
Table 74. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 75. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Argos Therapeutics Recent Development
Table 77. In-Cell-Art Company Detail
Table 78. In-Cell-Art Business Overview
Table 79. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
Table 80. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 81. In-Cell-Art Recent Development
Table 82. eTheRNA Company Detail
Table 83. eTheRNA Business Overview
Table 84. eTheRNA mRNA Cancer Vaccines and Therapeutics Product
Table 85. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 86. eTheRNA Recent Development
Table 87. Ethris Company Detail
Table 88. Ethris Business Overview
Table 89. Ethris mRNA Cancer Vaccines and Therapeutics Product
Table 90. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 91. Ethris Recent Development
Table 92. Tiba Biotechnology Company Detail
Table 93. Tiba Biotechnology Business Overview
Table 94. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
Table 95. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 96. Tiba Biotechnology Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Adeno Carcinomas Features
Figure 4. Mucinous Carcinomas Features
Figure 5. Adenosquamous Carcinomas Features
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Infectious Disease Case Studies
Figure 9. Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2023
Figure 16. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2023
Figure 18. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 20. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Region (2019-2030)
Figure 32. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 47. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 48. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 49. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 50. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 51. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 52. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 53. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 54. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 55. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Adeno Carcinomas
Table 3. Key Players of Mucinous Carcinomas
Table 4. Key Players of Adenosquamous Carcinomas
Table 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2019-2024)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2025-2030)
Table 11. mRNA Cancer Vaccines and Therapeutics Market Trends
Table 12. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 13. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 14. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 15. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2023)
Table 18. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
Table 22. Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Moderna Therapeutics Company Detail
Table 48. Moderna Therapeutics Business Overview
Table 49. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 50. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Moderna Therapeutics Recent Development
Table 52. CureVac Company Detail
Table 53. CureVac Business Overview
Table 54. CureVac mRNA Cancer Vaccines and Therapeutics Product
Table 55. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 56. CureVac Recent Development
Table 57. Translate Bio Company Detail
Table 58. Translate Bio Business Overview
Table 59. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
Table 60. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Translate Bio Recent Development
Table 62. BioNTech Company Detail
Table 63. BioNTech Business Overview
Table 64. BioNTech mRNA Cancer Vaccines and Therapeutics Product
Table 65. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 66. BioNTech Recent Development
Table 67. Sangamo Therapeutics Company Detail
Table 68. Sangamo Therapeutics Business Overview
Table 69. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 70. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Sangamo Therapeutics Recent Development
Table 72. Argos Therapeutics Company Detail
Table 73. Argos Therapeutics Business Overview
Table 74. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 75. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Argos Therapeutics Recent Development
Table 77. In-Cell-Art Company Detail
Table 78. In-Cell-Art Business Overview
Table 79. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
Table 80. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 81. In-Cell-Art Recent Development
Table 82. eTheRNA Company Detail
Table 83. eTheRNA Business Overview
Table 84. eTheRNA mRNA Cancer Vaccines and Therapeutics Product
Table 85. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 86. eTheRNA Recent Development
Table 87. Ethris Company Detail
Table 88. Ethris Business Overview
Table 89. Ethris mRNA Cancer Vaccines and Therapeutics Product
Table 90. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 91. Ethris Recent Development
Table 92. Tiba Biotechnology Company Detail
Table 93. Tiba Biotechnology Business Overview
Table 94. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
Table 95. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2019-2024) & (US$ Million)
Table 96. Tiba Biotechnology Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Adeno Carcinomas Features
Figure 4. Mucinous Carcinomas Features
Figure 5. Adenosquamous Carcinomas Features
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Infectious Disease Case Studies
Figure 9. Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2023
Figure 16. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2023
Figure 18. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 20. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Region (2019-2030)
Figure 32. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 47. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 48. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 49. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 50. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 51. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 52. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 53. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 54. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 55. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232